Monday, 6 Oct 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Bus World 2025: CRRC EV Debuts Two All-Electric Buses, Introduces Digital-Intelligent Low-Carbon Urban Transit System to Redefine Smarter Urban Mobility
    06/10/2025
    HKUST Scientists Reveal Critical Impacts of a Chinese Genetic Risk Factor in Alzheimer’s Disease
    HKUST Scientists Reveal Critical Impacts of a Chinese Genetic Risk Factor in Alzheimer’s Disease
    05/10/2025
    GSME Acquires Muse Semiconductor
    GSME Acquires Muse Semiconductor
    05/10/2025
    Cummins India Limited Commemorates 30 Years of Listing on NSE
    Cummins India Limited Commemorates 30 Years of Listing on NSE
    04/10/2025
    Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
    Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
    04/10/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  • june
  • announced
  • today
  •  and
  • july
  •  the
  • company
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Rakovina Therapeutics Announces Stock Option Grants

GlobeNews Wire
Last updated: 30/07/2025 3:19 AM
GlobeNews Wire
Share
5 Min Read
Rakovina Therapeutics Announces Stock Option Grants
SHARE
Rakovina Therapeutics Announces Stock Option Grants

July 29, 2025 17:00 ET  | Source: Rakovina Therapeutics Inc

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce that its board of directors has approved the grant of an aggregate of 540,000 stock options (the “Options”) to certain consultants, employees, officers and directors of the Company pursuant to the Company’s Long Term Incentive Plan.

Each Option is exercisable for up to five years at a price of $0.70 per share and shall vest in equal parts every six months over the next three years.

About Rakovina Therapeutics Inc.

Rakovina is a biopharmaceutical research company focused on the development of innovative cancer treatments. Their work is based on unique technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, they can review and optimize drug candidates at a much greater pace than ever before. The Company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Further information may be found at www.rakovinatherapeutics.com.

No regulatory authority has approved or disapproved the content of this press release. Neither the TSX Venture Exchange nor its Regulatory Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Notice Regarding Forward-Looking Statements

This press release may contain “forward-looking statements” regarding the Company and its respective business within the meaning of applicable Canadian securities laws, including, without limitations, statements regarding: the Company’s objectives, goals, or future plans regarding its cancer treatments or proposed business plan and expected results of the Company’s DDR platform. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic, and competitive uncertainties and contingencies. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved.

The forward-looking events and circumstances discussed in this press release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks regarding the medical device industry, economic factors, regulatory factors, the equity markets generally, and risks associated with growth and competition. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events, or results to differ from those anticipated, estimated, or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

The reader is referred to the Company’s most recent filings on SEDAR+ for a more complete discussion of all applicable risk factors and their potential effects, copies of which may be accessed through the Company’s profile page at www.sedarplus.ca.

For Further Information Contact:

Michelle Seltenrich, BSc MBA
Director, Corporate Development 
IR@rakovinatherapeutics.com 
778-773-5432

Golden Age Health and Innostellar Biotherapeutics Sign Exclusive 10-Year Collaboration to Accelerate LX-101 Gene Therapy for Inherited Retinal Dystrophies due to RPE 65 gene mutation in Mainland China
Qbic Catalyst Partners Unveils TechCell–India’s First Exclusive Community Platform for Engineering & Technology Students
Sanas Receives Frost & Sullivan’s 2025 North American Company of the Year Recognition for Leadership in Accent Translation Solutions
NYSE Content Advisory: Pre-Market Update + Alphabet shares pop 7% to lift S&P 500
Geospace Technologies Acquires National Lab Developed Heartbeat Detector Technology
TAGGED:advancingAdventureaipoweredannounceannouncesartificialbiopharmaceuticalboardbritishCA75103L1013cancercolumbiacompanydirectorsdiscoverydrugFrankfurt:7JO0fseglobegrantsincintelligencejulynewsnewswireoptionoptionspleasedrakovinarkvsourcestocktherapeuticstherapiesTSX-V:RKVtsxvvancouveryears
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Hisense Unveils ‘Boundless’ Vision at 2025 Laser Display Conference
Tech

Hisense Unveils ‘Boundless’ Vision at 2025 Laser Display Conference

19/09/2025
Scaling Self-Care Can Be a Game-Changer in Global Fight Against Non-Communicable Diseases
Health

Scaling Self-Care Can Be a Game-Changer in Global Fight Against Non-Communicable Diseases

24/07/2025
CDB Aviation and Loong Air Execute Lease Agreements for Six A321neo Aircraft
Business

CDB Aviation and Loong Air Execute Lease Agreements for Six A321neo Aircraft

21/07/2025
Foundation for Sarcoidosis Research Announces 2025 Global Virtual Sarcoidosis Summit  United for Progress: A New Chapter in Sarcoidosis
Health

Foundation for Sarcoidosis Research Announces 2025 Global Virtual Sarcoidosis Summit United for Progress: A New Chapter in Sarcoidosis

05/06/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?